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Background: Limited brachial artery (BA) flow-mediated dilation measured by brachial artery reactivity testing (BART) is a recognized non-invasive 
test of endothelial dysfunction that has been linked to increased cardiovascular risk. However, BA constriction (BAC) during BART has received 
limited attention.
Methods: We studied a WISE cohort of 377 women with chest pain referred for coronary angiography and BART and then followed for clinical 
outcomes. Calcium antagonists/nitrates were withheld for ≥24 hours prior to BART. Resting BA diameter was measured before and after forearm 
ischemia induced with 4 minutes occlusion by a cuff placed just distal to the BA and inflated to 40mm Hg > systolic pressure. BAC was defined 
as >5% artery constriction (1 standard deviation below the mean) following release of the cuff. Baseline evaluations included demographics, risk 
factors, blood assays and core lab quantitative angiography. Major adverse events included all-cause mortality, MI, heart failure, or stroke.
Results: Mean age was 58±11 years, 13% were non-white, and 36% had obstructive coronary artery disease (CAD) (≥50% stenosis in ≥1 epicardial 
vessel). BA diameter change ranged from -20.6% to 44.9% and 40 (11%) women experienced BAC, with rates consistent across the 4 WISE clinical 
sites (p=0.50). Independent predictors (p-values) of BAC were presence of pulmonary disease (0.006) and recent aspirin use (0.016), but together 
explained only 6% of the variance of BAC. CAD presence or severity and traditional CAD risk factors were not predictive of BAC. A total of 32.5% 
women with BAC experienced a major adverse event vs. 14.5% without BAC (p=0.005) at a median follow-up of 6.8 years. In multivariate Cox 
proportional hazards regression, BAC was a significant independent predictor of major adverse events (p=0.027) when adjusting for CAD severity, 
age, diabetes, systolic blood pressure, and aspirin use.
Conclusions: Women with suspected ischemia undergoing coronary angiography who demonstrate BAC during BART have double the risk for major 
adverse events. This risk was not accounted for by CAD or traditional risk factors. The novel risk marker of BAC requires further investigation in this 
female population.
